Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myelitis, Transverse | 1 | 2020 | 7 | 0.830 |
Why?
|
| Recovery of Function | 2 | 2020 | 236 | 0.790 |
Why?
|
| Spinal Cord Injuries | 1 | 2020 | 64 | 0.790 |
Why?
|
| Ethanol | 4 | 2009 | 331 | 0.270 |
Why?
|
| Muscle Weakness | 1 | 2011 | 48 | 0.220 |
Why?
|
| Early Diagnosis | 1 | 2020 | 99 | 0.200 |
Why?
|
| Bone Resorption | 3 | 2008 | 319 | 0.200 |
Why?
|
| Spine | 1 | 2020 | 125 | 0.190 |
Why?
|
| Central Nervous System Depressants | 2 | 2008 | 81 | 0.160 |
Why?
|
| Hospitalization | 1 | 2011 | 675 | 0.160 |
Why?
|
| Estradiol | 2 | 2009 | 245 | 0.150 |
Why?
|
| Osteoblasts | 2 | 2009 | 535 | 0.130 |
Why?
|
| Estrogen Receptor beta | 1 | 2009 | 59 | 0.090 |
Why?
|
| Estrogen Receptor alpha | 1 | 2009 | 110 | 0.090 |
Why?
|
| Adolescent | 1 | 2020 | 6883 | 0.090 |
Why?
|
| Lactation | 1 | 2008 | 68 | 0.080 |
Why?
|
| Bone Density | 2 | 2008 | 436 | 0.080 |
Why?
|
| Female | 6 | 2020 | 28947 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2009 | 1850 | 0.080 |
Why?
|
| Estrus | 1 | 2005 | 11 | 0.070 |
Why?
|
| Pregnancy, Animal | 1 | 2005 | 36 | 0.070 |
Why?
|
| Alcoholism | 1 | 2008 | 249 | 0.070 |
Why?
|
| Osteogenesis | 1 | 2008 | 380 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2006 | 345 | 0.070 |
Why?
|
| Middle Aged | 1 | 2020 | 13660 | 0.070 |
Why?
|
| Aging | 1 | 2009 | 767 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2009 | 1809 | 0.060 |
Why?
|
| Muscular Atrophy | 1 | 2011 | 76 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2005 | 377 | 0.050 |
Why?
|
| Rats | 4 | 2009 | 3593 | 0.050 |
Why?
|
| Humans | 2 | 2020 | 52957 | 0.040 |
Why?
|
| Age Factors | 1 | 2011 | 1267 | 0.040 |
Why?
|
| Pregnancy | 3 | 2008 | 2431 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2009 | 1840 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 3636 | 0.030 |
Why?
|
| Animals | 4 | 2009 | 14793 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2011 | 5644 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2011 | 6073 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2009 | 42 | 0.020 |
Why?
|
| Response Elements | 1 | 2009 | 37 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2009 | 116 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2009 | 100 | 0.020 |
Why?
|
| Ligands | 1 | 2009 | 256 | 0.020 |
Why?
|
| Protein Transport | 1 | 2009 | 207 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 2008 | 40 | 0.020 |
Why?
|
| Tibia | 1 | 2008 | 115 | 0.020 |
Why?
|
| Acetylcysteine | 1 | 2008 | 121 | 0.020 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2008 | 79 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2009 | 258 | 0.020 |
Why?
|
| Aged | 1 | 2011 | 10455 | 0.020 |
Why?
|
| Adipocytes | 1 | 2008 | 147 | 0.020 |
Why?
|
| Progesterone | 1 | 2006 | 80 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 110 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 214 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2005 | 43 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 442 | 0.020 |
Why?
|
| RANK Ligand | 1 | 2006 | 189 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2006 | 721 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2009 | 519 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 716 | 0.020 |
Why?
|
| Cell Division | 1 | 2005 | 370 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2006 | 538 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2006 | 412 | 0.020 |
Why?
|
| Gene Expression | 1 | 2006 | 717 | 0.020 |
Why?
|
| Osteoclasts | 1 | 2006 | 461 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 1145 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2008 | 966 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1572 | 0.010 |
Why?
|
| Male | 1 | 2011 | 28318 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 1295 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 3440 | 0.010 |
Why?
|
| Risk Factors | 1 | 2008 | 4005 | 0.010 |
Why?
|